
Carmell Corporation (CTCXW)
NASDAQ
The current CTCXW market cap is 616.29k. The company's latest EPS is USD -0.6984 and P/E is -0.29.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -467k | -1.65M | -5.94M |
Net Income | -329k | 205k | -16.12M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 155.42M | 156.98M | 63.95M |
Total Liabilities | 5.74M | 7.09M | 39.2M |
Total Equity | -4.76M | -6.02M | 24.75M |
Market Cap | 616.29k |
Price to Earnings Ratio | -0.29 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.58 |
Price to Book Ratio | 0.19 |
Dividend Yield | - |
Shares Outstanding | 23.08M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.03 (55%) |
Company Name | Carmell Corporation |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.carmellrx.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.